Trends in Metastatic Kidney Cancer Survival From the Cytokine to the Targeted Therapy Era-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Trends in Metastatic Kidney Cancer Survival From the Cytokine to the Targeted Therapy Era

Published:2015-08 Issue:2 Volume:86 Page:262-268
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Macleod Liam C.^ORCID,Tykodi Scott S.,Holt Sarah K.,Wright Jonathan L.,Lin Daniel W.,Tretiakova Maria S.,True Lawrence D.,Gore John L.

Publisher

Elsevier BV

Subject

Urology

Reference29 articles.

1. SEER Cancer Statistics Review, 1975-2010;Howlader,2013

2. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy;Fyfe;J Clin Oncol,1995

3. High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma : a retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006;Klapper;Cancer,2008

4. Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Francais d'Immunotherapie;Negrier;N Engl J Med,1998

5. Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial;Escudier;J Clin Oncol,2009

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Racial and Ethnic Disparities in Survival Outcomes of Metastatic Renal Cell Carcinoma Patients Receiving Immunotherapy;Clinical Genitourinary Cancer;2024-08

2. Differences in overall survival between clear cell metastatic renal cell carcinoma patients versus population-based controls according to race/ethnicity in the United States;Annals of Epidemiology;2023-03

3. Clear Cell Renal Cell Carcinoma: From Biology to Treatment;Cancers;2023-01-21

4. Contemporary vs historical survival rates in metastatic clear cell renal carcinoma according to race/ethnicity;World Journal of Urology;2022-10-12

5. An integrated pan-cancer analysis of identifying biomarkers about the EGR family genes in human carcinomas;Computers in Biology and Medicine;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3